In a report released today, David Grossman from Stifel Nicolaus maintained a Buy rating on OptimizeRx (OPRX – Research Report), with a ...
Federal health scientists voice concern over an anticipated takeover by medical skeptics in Trump’s second administration ...
Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...